Prolia® (denosumab) Arriving Worldwide for the treatment of postmenopausal osteoporosis — ...

Prolia® (denosumab) Arriving Worldwide for the treatment of postmenopausal osteoporosis — ...

Prolia® (denosumab) Arriving Worldwide for the treatment of postmenopausal osteoporosis — ...

(Klikken: 151;website toegevoegd: Mar 24, 2014)

Beschrijving:

Prolia® (denosumab), the first and only approved RANK Ligand inhibitor, has filed for approval worldwide for the treatment of postmenopausal osteoporosis.